TGA webinar on changes to regulation
This webinar is targeted at current providers of HCT, to assist with interpreting the changes and likely impact. It will provide an overview of the changes to the regulation of autologous HCT, including guidance on restrictions to advertising content and the need to report adverse events from 1 July 2018.
Please note the recent TGA publication of guidance on the upcoming changes to the regulation of autologous human cells and tissues(HCT)products.
You can register for the event through the TGA website.